The global injection pen market sales is expected to have risen at a 7.0% compound annual growth rate (CAGR) from US$ 40.7 billion in 2022 to US$ 85.8 billion by the end of 2033. Over the course of the projection period, the global injection pen market is expected to grow at a 7% CAGR, from US$ 38 billion in 2021 to US$ 53 billion in 2032.
Because of the increased frequency of needle stick injuries, there is a growing preference for injectable pens over the traditional vial and needle technique, which is driving market growth. FMI presents an in-depth analysis of the Injection Pen market, based on the most recent insights and statistics from the world’s largest pharmaceutical and healthcare device manufacturers.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-14315
Over the past decade, healthcare sector has been expanding remarkably, following the advent of artificial Intelligence and the Internet of Things integrated medical devices. Advancement in technology has created impressive scope within the medical sector for diagnostics and therapeutics.
The report offers extensive data sets validating key trends impacting growth in the Injection Pen market. It offers insights into strategies adopted by the key players rise and address the concerns that will challenge the growth of Injection Pen market. With our extensive research and information about the past, current and future market scenario, the Injection Pen market report will help and identify the concerns, for a smooth-sail of the small & medium as well as large enterprises.
Competitive Analysis
By Prominent Market Players
Key Players:
include Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (US), Ypsomed Holding AG (Switzerland), Sanofi (France), Eli Lilly and Company (US), Merck KGaA (Germany), AstraZeneca plc (UK), F. Hoffmann-La Roche Ltd. (Switzerland), Owen Mumford (UK), Sulzer Ltd. Sun Pharmaceutical Industries Ltd. (India), Pfizer (US), Biocon Ltd. (India), Lupin Ltd. (India), Wockhardt Ltd. (India), AptarGroup, Inc. (the US).
With an extensive SWOT analysis, the FMI’s study presents the strengths, weaknesses, growth prospects and challenges of each player. The report also includes important data including the sales strategy, pricing strategy, and marketing strategy adopted by these players in the Injection Pen mark.
Key Segments:
By Product Type:
- Disposable Injection Pens
- Reusable Injection Pens
By Therapy:
- Diabetes
-
- Insulin therapy
- GLP-1 therapy
- Insulin therapy
- Growth Hormone
- Osteoporosis
- Fertility
- Auto-immune Diseases
- Cancer
- Other Therapies
By End User:
- Home-care Settings
- Hospitals & Diagnostic Clinics
Elevate Strategy: Tap into Analyst Expertise Now:
https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-14315
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube